Jay M. Haynie, DO, FAAO: A Leading Faculty Member's Bio

Overview
Not only is Dr. Jay Haynie the Executive Clinical Director of Retina and Macula Specialists, but he's also been a clinical investigator for Rainier Research, which has provided ocular examinations for patients undergoing experimental drug therapy for diabetes, cholesterol, and diabetic neuropathy. In this series, Saving Sight, Preventing Vision Loss in Diabetic Retinopathy and Diabetic Macular Edema, hear his expertise on treating vision-threatening eye diseases in patients with diabetes.

- Diana Shechtman, OD, FAAO
  Peer
2
NEI Blindness Prevention Initiative
Patient Education: A Lifetime of Vision
Patient Education: A Lifetime of Vision
Patient Education: A Lifetime of Vision
1
NEI Blindness Prevention Initiative
Staging of Nonproliferative Diabetic Retinopathy
Staging of Nonproliferative Diabetic Retinopathy
Staging of Nonproliferative Diabetic Retinopathy
- Rahul N. Khurana, MD
  Peer
- Jennifer K. Sun, MD, MPH
  Peer
10
CME/CE
What You Need to Know About Strategies for Treating NPDR
What You Need to Know About Strategies for Treating NPDR
0.25 credits
What You Need to Know About Strategies for Treating NPDR
0.25 credits
- Ruth S. Weinstock, MD, PhD
  Peer
- Susan B. Bressler, MD
  Peer
- Mark Dunbar, OD, FAAO
  Peer
16
CME/CE
Saving Sight: What You Might Be Missing in Your Patients with Diabetes
Saving Sight: What You Might Be Missing in Your Patients with Diabetes
0.25 credits
Saving Sight: What You Might Be Missing in Your Patients with Diabetes
0.25 credits

Eye Health Academy